The pandemic resulting from the outbreak of coronavirus around the world, after all, turned out to be more of a boon than a bane for world and domestic medicine . This was stated by Dmytro Shymkiv – the chairman of the board of directors of Darnitsa Group. According to him, there are four areas confidently developing now, which will subsequently change the global pharmaceutical industry.
The first is computer simulation. Digital computing makes it possible to predict how a particular virtual protein will affect the structural components of the Covid-19 coronavirus. Also, using this technology, it is possible to simulate the behavior of this and other viruses in the human body and the response of disease-causing cells to therapy. In future, this computer development will help to significantly reduce the time of in vitro studies – those that are carried out in laboratory conditions, or “in the tube”.
The second is DNA and RNA sequencing. For the first time, the coronavirus genome was decoded in January 2020. By the end of the same month, 28 genome variants had already been registered in the Chinese genetic database GenBank. A month later, dozens of countries began the sequencing process. This was the beginning of the development of 166 coronavirus vaccines, as well as potential cures for it. Scientists are researching the genetic dependence, which determines the severity of the course of the disease alongside studying the Covid-19 genome. Dmytro Shymkiv emphasized that such studies used to cost about $30 thousand. Now their cost does not exceed $100. This means that in the near future even small laboratories will be able to afford sequencing.
The third is AI (artificial intelligence) and BigData. Computer systems, due to collecting and storing millions of medical histories and medical records, as well as information on the effectiveness of drugs, will be able to generate treatment protocols and suggest therapy tactics to doctors. In terms of fighting against coronavirus, AI can play a decisive role in the process of breaking the chain spread of Covid-19. So Health Services will be able to track the movements and contacts of infected people and assess the risks of outbreaks. This will help substitute the practice of total lockdowns with the targeted introduction of quarantine measures.
And the last thing that, according to Dmytro Shymkiv, will change the way people, not only Ukrainians, but all the people worldwide think about pharmaceutics and medical practice – is telemedicine. Remote reception and counseling using voice and video communication started to be actively used precisely during the pandemic. For people at risk this method of contact with a doctor was the only possibility to receive medical advice. But even when the incidence rate began to decline, remote counseling did not lose its relevance and significantly simplified the work of doctors and the life of patients.